MIK665
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MIK665, covering 2025-10-10 to 2025-10-10. Get the full timeline:
Most recent: Clinical Trial Update: VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) [Phase 1]